OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
102
Results
Show all
Save search
Copy query
Show results for
Unknown
(102)
Publication Date
Release Date
2025
(12)
2016
(12)
2024
(11)
2022
(11)
2020
(9)
2023
(8)
2019
(8)
2015
(7)
2021
(6)
2014
(5)
2018
(4)
2017
(3)
2013
(3)
2026
(1)
2010
(1)
2007
(1)
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
Community health literacy outcome measurement practices: A scoping review of recent interventions.
Not available
S-EPMC9455946
|
biostudies-literature
Cite
Sleep and health-related quality of life in women following a cancer diagnosis: results from the Women's Wellness after Cancer Program in Australia.
Not available
S-EPMC9715466
|
biostudies-literature
Cite
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.
Not available
S-EPMC2200912
|
biostudies-literature
Cite
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naive patients with metastatic melanoma.
Not available
S-EPMC6279094
|
biostudies-literature
Cite
Prospective observational study in patients with obstructive lung disease: NOVELTY design.
Not available
S-EPMC6355976
|
biostudies-literature
Cite
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
Not available
S-EPMC12011061
|
biostudies-literature
Cite
Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study.
Not available
S-EPMC4747478
|
biostudies-literature
Cite
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
Not available
S-EPMC8275355
|
biostudies-literature
Cite
Effect of Bacille Calmette-Guerin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination.
Not available
S-EPMC11761716
|
biostudies-literature
Cite
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial.
Not available
S-EPMC7703447
|
biostudies-literature
Cite
Previous
page
1 / 11
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
11
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets